These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36300496)

  • 1. [Regulated market failure in healthcare; quality comparisons can improve competition in the Dutch healthcare market].
    Nederpelt CJ; Mostert CQB; van den Hout WB
    Ned Tijdschr Geneeskd; 2022 Oct; 166():. PubMed ID: 36300496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competition and quality indicators in the health care sector: empirical evidence from the Dutch hospital sector.
    Croes RR; Krabbe-Alkemade YJFM; Mikkers MC
    Eur J Health Econ; 2018 Jan; 19(1):5-19. PubMed ID: 28050682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public healthcare interests require strict competition enforcement.
    Loozen EM
    Health Policy; 2015 Jul; 119(7):882-8. PubMed ID: 25739723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the relationship between healthcare market competition and medical care quality under Taiwan's National Health Insurance programme.
    Liao CH; Lu N; Tang CH; Chang HC; Huang KC
    Eur J Public Health; 2018 Dec; 28(6):1005-1011. PubMed ID: 29873710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of market competition on hospital performance for heart failure.
    Maeda JL; LoSasso AT
    Am J Manag Care; 2011 Dec; 17(12):816-22. PubMed ID: 22216752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Making Markets in Long-Term Care: Or How a Market Can Work by Being Invisible.
    Grit K; Zuiderent-Jerak T
    Health Care Anal; 2017 Sep; 25(3):242-259. PubMed ID: 25953060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital cost and quality performance in relation to market forces: an examination of U.S. community hospitals in the "post-managed care era".
    Jiang HJ; Friedman B; Jiang S
    Int J Health Care Finance Econ; 2013 Mar; 13(1):53-71. PubMed ID: 23355253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does price deregulation in a competitive hospital market damage quality?
    Roos AF; O'Donnell O; Schut FT; Van Doorslaer E; Van Gestel R; Varkevisser M
    J Health Econ; 2020 Jul; 72():102328. PubMed ID: 32599157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Netherlands: health system review.
    Schäfer W; Kroneman M; Boerma W; van den Berg M; Westert G; Devillé W; van Ginneken E
    Health Syst Transit; 2010; 12(1):v-xxvii, 1-228. PubMed ID: 21132996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dutch healthcare reform: did it result in better patient experiences in hospitals? A comparison of the consumer quality index over time.
    Ikkersheim DE; Koolman X
    BMC Health Serv Res; 2012 Mar; 12():76. PubMed ID: 22443174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Care Exceptionalism? Performance and Allocation in the US Health Care Sector.
    Chandra A; Finkelstein A; Sacarny A; Syverson C
    Am Econ Rev; 2016 Aug; 106(8):2110-2144. PubMed ID: 27784907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators.
    Portrait FR; van der Galiën O; Van den Berg B
    Health Econ; 2016 Apr; 25(4):408-23. PubMed ID: 25702821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accountable care organizations and antitrust: restructuring the health care market.
    Scheffler RM; Shortell SM; Wilensky GR
    JAMA; 2012 Apr; 307(14):1493-4. PubMed ID: 22496262
    [No Abstract]   [Full Text] [Related]  

  • 14. Perceptions of and support for national health insurance in South Africa's public and private healthcare sectors.
    Booysen F; Hongoro C
    Pan Afr Med J; 2018; 30():277. PubMed ID: 30637062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing quality indicators for general practice care for vulnerable elders; transfer from US to The Netherlands.
    van der Ploeg E; Depla MF; Shekelle P; Rigter H; Mackenbach JP
    Qual Saf Health Care; 2008 Aug; 17(4):291-5. PubMed ID: 18678728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objectives, methods, and results in critical health systems and policy research: evaluating the healthcare market.
    Unger JP; Morales I; De Paepe P
    BMC Health Serv Res; 2020 Dec; 20(Suppl 2):1072. PubMed ID: 33292212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation and coordination in Dutch health care policy-making. A network analysis of the system of intermediate organizations in Dutch health care.
    Lamping AJ; Raab J; Kenis P
    Health Promot Int; 2013 Jun; 28(2):211-22. PubMed ID: 22411896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Market competition: everybody is talking, but what do they say?. A sociological analysis of market competition in policy networks.
    Paulus A; van Raak A; van der Made J; Mur-Veeman I
    Health Policy; 2003 Jun; 64(3):279-89. PubMed ID: 12745167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Netherlands: Health System Review.
    Kroneman M; Boerma W; van den Berg M; Groenewegen P; de Jong J; van Ginneken E
    Health Syst Transit; 2016 Mar; 18(2):1-240. PubMed ID: 27467715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (I can't get no) satisfaction: A comparative study of healthcare recommodification in Europe, 2010-18.
    Martinussen PE; Rydland HT
    Soc Sci Med; 2022 Jul; 305():115083. PubMed ID: 35640446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.